Official Twitter account of the National Alliance for Sickle Cell Centers. Providing support to centers around the nation in the pursuit of equitable treatment.
I cannot say enough about the amazing time we spent with @ololhealth last week in a #SCDWorkshop to improve outcomes and management for people living with #sicklecelldisease#SCD The BEST attendance and engagement of anywhere in 2026 (so far)!
NIH is leading the way in advancing research for sickle cell disease.
Dr. Griffin P. Rodgers’ pioneering research helped establish hydroxyurea as the first FDA-approved treatment for sickle cell disease, reducing pain crises, hospitalizations, and mortality worldwide.
An innovative stem cell transplant regiment, developed by Dr. Rodgers and collaborators at NIH, has reversed sickle cell disease in many patients. Meanwhile, his colleagues’ innovative work in gene therapy is advancing a possible cure for the disease.
We’re proud to celebrate Dr. Rodger’s receipt of the John Phillips Memorial Award for Outstanding Work in Clinical Medicine. https://t.co/uTAOITIVA5
We must TREAT pain in #sicklecelldisease quickly and aggressively. We must STOP measuring pain. We need to measure causes of pain (inflammation, hemolysis, adhesion) to measure the effect of new tx. @US_FDA it’s time to use a new endpoint. #TogetherWeCan
https://t.co/jf42SQ4xC5
The room is full here at the @nascc_org meeting in Stowe, Vermont. Over 300 people in attendance to discuss topics related to Sickle Cell Disease. Looking forward to an exciting week ahead. #NASCC2025#sicklecellmatters#sicklecellcenters2025
We are excited about our partnership w/ #Quilthealth. They share our commitment to reimagining how people access healthcare. Our missions align in putting people first, removing barriers, & using technology to drive real change. #peoplefirst#sicklecell#accesstocare
Big news from @QuiltHealth: We raised $6 M in seed funding (led by @MaCVentureCapital) & partnering with @nascc_org to launch a platform that:
🧪 Expands trial access
📈 Boosts patient/provider insights
🧩 Tackles care disparities
Read more: https://t.co/Y2fsWWwI0t
#RareDiseaseDay2025 highlights unseen struggles of the survivors. #SickleCellDisease, a life-threatening rare genetic disorder, remains underrepresented in research & care.
HemexDx is committed to #earlydiagnosis of SCA. Let’s raise #awareness & drive innovation!